Meeting of the   immunization Strategic   Advisory Group of   Experts, November   2008--conclusions and   recommendations.
D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000627:therapeutic use; D030361:Papillomavirus Infections / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D011051:Poliomyelitis / Q000517:prevention & control; D023321:Poliovirus Vaccines / Q000627:therapeutic use; D012400:Rotavirus Infections / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000627:therapeutic use; D014612:Vaccines / Q000627:therapeutic use*; D014944:World Health Organization
D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D008458:Measles Vaccine; D053918:Papillomavirus Vaccines; D023321:Poliovirus Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines